AI assistant
Sending…
Moleculin Biotech, Inc. — Director's Dealing 2016
Jun 8, 2016
34881_dirs_2016-06-07_2b52e34c-d522-42b0-baa8-830b66704491.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Moleculin Biotech, Inc. (MBRX)
CIK: 0001659617
Period of Report: 2016-06-02
Reporting Person: CANNON MICHAEL D (Director)
More from Moleculin Biotech, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 8
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 15